On 17 July 2018, the company Oakshire Naturals, LP. (‘the applicant’) submitted a request to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to place vitamin D2 mushroom powder on the Union market as a novel food. The application concerns the use of vitamin D2 mushroom powder in a variety of foods and beverages for consumption by the general population, in foods for special medical purposes as defined in Regulation (EU) No 609/2013 of the European Parliament and of the Council [Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 (OJ L 181, 29.6.2013, p. 35).] excluding those intended for infants, and in food supplements as defined in Directive 2002/46/EC of the European Parliament and of the Council [Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements (OJ L 183, 12.7.2002, p. 51).], intended for individuals above 7 months of age.
Recital 4, Regulation (EU) 2020/1163
In forcesince 6 Aug 2020
Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 201…Law
- celex=31992L0052
- celex=32009L0039
- celex=32009R0041
- celex=32009R0953
- num:eu=1941/2009
- num:eu=1992/52
- num:eu=1999/21
- num:eu=2006/141
- num:eu=2009/39